The Data Quality Campaign Becomes National Cyber Security Awareness Month Champion

WASHINGTON, DC, September 5, 2014—The Data Quality Campaign joins a growing global effort among government, corporate, non-profit, and academic sectors to promote online safety awareness.

As an official champion of National Cyber Security Awareness Month (NCSAM) 2014, the Data Quality Campaign (DQC) will promote cyber security awareness resources online and through social media.

“We’re excited to announce this new partnership with the National Cyber Security Alliance (NCSA). Their expertise and dedication to cyber security will prove valuable as we continue to promote the safeguarding of student data and its use to improve student achievement,” said Aimee Rogstad Guidera, executive director of the Data Quality Campaign.

DQC proudly supports public awareness programs like NCSAM. Trust in education data use and personal information practices must be created by increasing transparency and awareness, demonstrating to parents, students, and teachers the benefits and promise of data use and technology.”

Celebrated every October for the past 11 years, National Cyber Security Awareness Month was created to ensure everyone has the resources needed to stay safer and more secure online.

The NCSA is a non-profit organization whose mission is to educate and empower a digital citizenry to use the Internet securely and safely. It is dedicated to providing industries, communities and individuals with the tools and resources to protect themselves and the digital assets we all share.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.